Application of luteinizing hormone-releasing hormone–ferrosoferric oxide nanoparticles in targeted imaging of breast tumors [PDF]
Background Ferrosoferric oxide (Fe 3 O 4 ) nanoparticles are a commonly used magnetic resonance imaging (MRI) reagent. Luteinizing hormone-releasing hormone (LHRH) is highly expressed on the surfaces of tumors, but its expression is low or absent in the ...
Di Nian+5 more
doaj +7 more sources
Biocompatibility and Toxicity of Polylactic Acid/Ferrosoferric Oxide Nanomagnetic Microsphere [PDF]
Magnetic targeted drugs delivery system (MTDDS) is a new targeted drug system, which can greatly reduce the dosage and improve the therapeutic efficiency of medicine. Currently superparamagnetic ferric oxide plays important function as targeted drug in the treatment of tumors, but cytotoxicity was still regarded as side effect in the process of drug ...
Hongzhao Xiang+3 more
wiley +5 more sources
The Kinetic Simulation of Persulfate Activation by Nano-Ferrosoferric Oxide [PDF]
Nano-ferrosoferric-oxide (nFe3O4)-activated persulfate (PS) technology was used to remove pollutant bisphenol A (BPA) in water. The effects of nFe3O4 concentration, PS concentration, BPA concentration, temperature, and pH were investigated in terms of the degradation effect of BPA.
Tiehong Song+4 more
semanticscholar +3 more sources
Capacitive Ferrosoferric Oxide as an Anode to Enhance the Electrical Energy Output and Storage of Microbial Fuel Cells [PDF]
Microbial fuel cells (MFCs) are electrochemical electricity generation devices that use microorganisms to degrade organic matter to produce electrical energy. The anode of microbial fuel cells (MFCs) is the carrier to which electrogenic microorganisms attach. However, traditional anodes do not have a storage function, which limits the application scope
Yuyang Wang+3 more
semanticscholar +3 more sources
Black iron oxide pigment has been successfully prepared by traditional method. Ferrous sulphate was used as the starting iron source. The effect of amount of acid, type and amount of alkali and oxidizing agent on colour and yield were also studied. It was found that, the conversion of insitu produced ferrous chloride to ferrosoferric oxide yielded ...
Ajm Tahuran Neger+3 more
semanticscholar +5 more sources
This article has been removed: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).This article has been removed at the request of the Executive Publisher.This article has been removed because it was published without the permission of the author(s).
Tingbi Li, Ping Yu, Yunbai Luo, H. Li
semanticscholar +4 more sources
This paper deals with the effect of preparation parameter on particle size and microstructure of the prepared ferrosoferric oxide. 10 prepared samples (from 23 samples) and one standard sample (Bayferrox 318 standard 88) collected from BAYER, Germany was selected for this study.
Ajm Tahuran Neger+3 more
semanticscholar +5 more sources
A novel tri-mode detection platform for ampicillin and drug resistance genes by CRISPR-driven luminescent nanozymes [PDF]
The antibiotic residues pose significant risks for bacterial resistance. To address the practical requirements for rapid, accurate, and on-site detection of antibiotic residues and monitoring the abundance of associated resistance genes, we report a ...
Tao Zhang+5 more
doaj +3 more sources
The Ayurvedic Management of Fungal Sinusitis in Standalone Settings: A Case Report. [PDF]
ABSTRACT A 42‐year‐old female with left nasal blockage, facial numbness, upper palate pain, and headache was diagnosed with fungal ball sinusitis via CT scan. Refusing surgery, she opted for Ayurveda. Comprehensive treatment led to complete symptom resolution and a clear CT scan at 3 months.
Patel R+4 more
europepmc +2 more sources
Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency. [PDF]
Abstract Iron deficiency (ID) is a common co‐morbidity in patients with heart failure (HF). The present meta‐analysis evaluates the effect of intravenous (IV) iron‐carbohydrate complex supplementation in patients with HF with reduced ejection fraction (HFrEF) and ID/iron deficiency anaemia (IDA).
Sindone A, Doehner W, Comin-Colet J.
europepmc +2 more sources